{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "G2019S is the most common known genetic cause of PD and is associated with familial and to a lesser extent non-familial cases. G2019S has higher activity in kinase activity assays [3][4][5][6][7][8][9] and was recently shown to have an altered ATP K m,app [8].",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism (Parkinson's disease) and links it to the functional assays (kinase activity) for the G2019S variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays used are kinase activity assays, which are standard techniques in the field for assessing enzyme function and disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays are widely accepted and applicable for studying the functional impact of mutations in enzymes like LRRK2, which is implicated in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not explicitly mention basic controls, replicates, or statistical analyses for the G2019S variant. However, it references previously determined IC50 values from activity assays [8], suggesting some validation.",
          "judgment": "Yes",
          "reasoning": "While specific controls and replicates are not detailed, the assay type is broadly accepted and validated in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G2019S has higher activity in kinase activity assays and an altered ATP K m,app, consistent with a gain-of-function mechanism.",
          "judgment": "Pathogenic",
          "reasoning": "The consistent evidence of increased kinase activity strongly supports a pathogenic role for G2019S in Parkinson's disease."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant shows consistent evidence of increased kinase activity and altered ATP binding, supporting its pathogenic role in Parkinson's disease. The evidence is considered supporting due to the lack of explicit controls and replicates in the specific study."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "I2020T has lower kinase activity in assays measuring substrate phosphorylation [4,8], whereas it was demonstrated to have either higher activity or unchanged activity in autophosphorylation assays [6,10].",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism (Parkinson's disease) and links it to the functional assays (kinase activity) for the I2020T variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The assays used are kinase activity assays, which are standard techniques in the field for assessing enzyme function and disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays are widely accepted and applicable for studying the functional impact of mutations in enzymes like LRRK2, which is implicated in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper does not explicitly mention basic controls, replicates, or statistical analyses for the I2020T variant. However, it references previously determined IC50 values from activity assays [8], suggesting some validation.",
          "judgment": "Yes",
          "reasoning": "While specific controls and replicates are not detailed, the assay type is broadly accepted and validated in the field.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "I2020T shows lower activity in substrate phosphorylation assays but higher or unchanged activity in autophosphorylation assays, suggesting a complex functional impact.",
          "judgment": "Pathogenic",
          "reasoning": "The mixed evidence of altered kinase activity (lower in substrate phosphorylation, higher in autophosphorylation) suggests a potential pathogenic role, though the effect is less clear compared to G2019S."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The I2020T variant shows mixed evidence of altered kinase activity, with lower activity in substrate phosphorylation and higher or unchanged activity in autophosphorylation. While this suggests a potential pathogenic role, the evidence is less strong compared to G2019S, and is therefore considered supporting."
    }
  ]
}